Terms: = Lung cancer AND PML, TRIM19, 5371, ENSG00000140464, MYL, PP8675, RNF71 AND Treatment
25 results:
1. Population Pharmacokinetics of myl-1402O, a Proposed Biosimilar to Bevacizumab and Reference Product (Avastin
Owen JS; Rackley RJ; Hummel MA; Roepcke S; Huang H; Liu M; Idris TA; Murugesan SMN; Marwah A; Loganathan S; Ranganna G; Barve A; Waller CF; Socinski MA
Eur J Drug Metab Pharmacokinet; 2023 Nov; 48(6):675-689. PubMed ID: 37792130
[TBL] [Abstract] [Full Text] [Related]
2. Killing Two Birds With One Stone: Effective Control of Both Non-Small Cell lung cancer and Progressive Multifocal Leukoencephalopathy With Atezolizumab, A Case Report.
Lambert N; El Moussaoui M; Ritacco C; Moïse M; Paulus A; Delvenne P; Baron F; Sadzot B; Maquet P
Front Immunol; 2022; 13():889148. PubMed ID: 35592313
[TBL] [Abstract] [Full Text] [Related]
3. myl-1402O: A Bevacizumab Biosimilar.
Lee A
Target Oncol; 2022 Jan; 17(1):85-88. PubMed ID: 34910269
[TBL] [Abstract] [Full Text] [Related]
4. Analytical similarity assessment of myl-1402O to reference Bevacizumab.
Goyal P; Vats B; Subbarao M; Honnappa CG; Kabadi P; Rohil S; Bera A; Mehta GR; Pai H; Adhikari L; Tagore R; Sharma S; Venkatachala R; Nair P; Annegowda S; Sahu A; Trivedi S; Shastri N; Gokhale Y; Thomas R; Thakur A; Mohan D; Rao K U; Melarkode R; Ullanat R
Expert Opin Biol Ther; 2022 Feb; 22(2):271-298. PubMed ID: 34465264
[TBL] [Abstract] [Full Text] [Related]
5. Successful treatment of Therapy-related Acute Promyelocytic Leukemia with All-trans-retinoic acid Following Epirubicin for Hepatocellular Carcinoma and Docetaxel and Pembrolizumab Therapies for lung Carcinoma: A Triple Malignancy Case.
Suzuki R; Kawai H; Furuya D; Akashi H; Ogawa Y; Kawada H; Ando K
Tokai J Exp Clin Med; 2020 Jul; 45(2):92-96. PubMed ID: 32602108
[TBL] [Abstract] [Full Text] [Related]
6. Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review.
Ishii K; Yamamoto F; Homma S; Okada Y; Nakamichi K; Saijo M; Tamaoka A
BMC Neurol; 2019 Oct; 19(1):263. PubMed ID: 31672142
[TBL] [Abstract] [Full Text] [Related]
7. Preoperative respiratory muscle endurance training improves ventilatory capacity and prevents pulmonary postoperative complications after lung surgery.
Laurent H; Aubreton S; Galvaing G; Pereira B; Merle P; Richard R; Costes F; Filaire M
Eur J Phys Rehabil Med; 2020 Feb; 56(1):73-81. PubMed ID: 31489810
[TBL] [Abstract] [Full Text] [Related]
8. Pembrolizumab treatment for Progressive Multifocal Leukoencephalopathy.
Cortese I; Muranski P; Enose-Akahata Y; Ha SK; Smith B; Monaco M; Ryschkewitsch C; Major EO; Ohayon J; Schindler MK; Beck E; Reoma LB; Jacobson S; Reich DS; Nath A
N Engl J Med; 2019 Apr; 380(17):1597-1605. PubMed ID: 30969503
[TBL] [Abstract] [Full Text] [Related]
9. S100A3 a partner protein regulating the stability/activity of RARα and pml-RARα in cellular models of breast/lung cancer and acute myeloid leukemia.
Gianni M; Terao M; Kurosaki M; Paroni G; Brunelli L; Pastorelli R; Zanetti A; Lupi M; Acquavita A; Bolis M; Fratelli M; Rochette-Egly C; Garattini E
Oncogene; 2019 Apr; 38(14):2482-2500. PubMed ID: 30532072
[TBL] [Abstract] [Full Text] [Related]
10. RNA-Seq analysis for the potential targets and molecular mechanisms of 17 β-estradiol in squamous cell lung carcinoma.
Chen X; Wu R; Wang S; Duan Q; Xuan Y
Neoplasma; 2016; 63(3):394-401. PubMed ID: 26952511
[TBL] [Abstract] [Full Text] [Related]
11. Dual promoter usage as regulatory mechanism of let-7c expression in leukemic and solid tumors.
Pelosi A; Careccia S; Sagrestani G; Nanni S; Manni I; Schinzari V; Martens JH; Farsetti A; Stunnenberg HG; Gentileschi MP; Del Bufalo D; De Maria R; Piaggio G; Rizzo MG
Mol Cancer Res; 2014 Jun; 12(6):878-89. PubMed ID: 24637061
[TBL] [Abstract] [Full Text] [Related]
12. Significant improvement following combination treatment with mefloquine and mirtazapine in a patient with progressive multifocal leukoencephalopathy after allogeneic peripheral blood stem cell transplantation.
Yoshida H; Ohshima K; Toda J; Kusakabe S; Masaie H; Yagi T; Ishikawa J
Int J Hematol; 2014 Jan; 99(1):95-9. PubMed ID: 24264833
[TBL] [Abstract] [Full Text] [Related]
13. Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects.
Ferreira AK; Santana-Lemos BA; Rego EM; Filho OM; Chierice GO; Maria DA
Br J Cancer; 2013 Nov; 109(11):2819-28. PubMed ID: 24201752
[TBL] [Abstract] [Full Text] [Related]
14. Inhibition of CK2 enhances UV-triggered apoptotic cell death in lung cancer cell lines.
Zhao T; Jia H; Li L; Zhang G; Zhao M; Cheng Q; Zheng J; Li D
Oncol Rep; 2013 Jul; 30(1):377-84. PubMed ID: 23595577
[TBL] [Abstract] [Full Text] [Related]
15. Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing.
Ong FS; Das K; Wang J; Vakil H; Kuo JZ; Blackwell WL; Lim SW; Goodarzi MO; Bernstein KE; Rotter JI; Grody WW
Expert Rev Mol Diagn; 2012 Jul; 12(6):593-602. PubMed ID: 22845480
[TBL] [Abstract] [Full Text] [Related]
16. Potential of anti-cancer therapy based on anti-miR-155 oligonucleotides in glioma and brain tumours.
Poltronieri P; D'Urso PI; Mezzolla V; D'Urso OF
Chem Biol Drug Des; 2013 Jan; 81(1):79-84. PubMed ID: 22834637
[TBL] [Abstract] [Full Text] [Related]
17. The SUMO E3-ligase PIAS1 regulates the tumor suppressor pml and its oncogenic counterpart pml-RARA.
Rabellino A; Carter B; Konstantinidou G; Wu SY; Rimessi A; Byers LA; Heymach JV; Girard L; Chiang CM; Teruya-Feldstein J; Scaglioni PP
Cancer Res; 2012 May; 72(9):2275-84. PubMed ID: 22406621
[TBL] [Abstract] [Full Text] [Related]
18. Nuclear epidermal growth factor receptor modulates cellular radio-sensitivity by regulation of chromatin access.
Dittmann K; Mayer C; Fehrenbacher B; Schaller M; Kehlbach R; Rodemann HP
Radiother Oncol; 2011 Jun; 99(3):317-22. PubMed ID: 21704408
[TBL] [Abstract] [Full Text] [Related]
19. A pilot study of bevacizumab and interferon-α2b in ocular melanoma.
Guenterberg KD; Grignol VP; Relekar KV; Varker KA; Chen HX; Kendra KL; Olencki TE; Carson WE
Am J Clin Oncol; 2011 Feb; 34(1):87-91. PubMed ID: 20458209
[TBL] [Abstract] [Full Text] [Related]
20. pml-IV functions as a negative regulator of telomerase by interacting with TERT.
Oh W; Ghim J; Lee EW; Yang MR; Kim ET; Ahn JH; Song J
J Cell Sci; 2009 Aug; 122(Pt 15):2613-22. PubMed ID: 19567472
[TBL] [Abstract] [Full Text] [Related]
[Next]
